id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-P-4596-0004,FDA,FDA-2023-P-4596,"Determination That MEPHYTON (Phytonadione) Tablets, 5 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,,2023-12-19T16:46:30Z,2023-27858,0,0,0900006486346c55
FDA-2023-P-4596-0005,FDA,FDA-2023-P-4596,"Response Letter from FDA CDER to Lachman Consulting Services, Inc.",Other,Denial of Petition,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,,2023-12-19T21:21:40Z,,0,0,0900006486349054
FDA-2023-P-4596-0001,FDA,FDA-2023-P-4596,"Citizen Petition from Lachman Consultant Services, Inc.",Other,Citizen Petition,2023-10-18T04:00:00Z,2023,10,2023-10-18T04:00:00Z,,2023-12-19T21:02:39Z,,0,0,09000064861053d8
FDA-2023-P-4596-0002,FDA,FDA-2023-P-4596,Acknowledgment Letter from FDA DMS to Lachman Consulting Services Inc,Other,Acknowledgement Letter/Receipt,2023-10-18T04:00:00Z,2023,10,2023-10-18T04:00:00Z,,2023-10-19T13:36:51Z,,0,0,09000064861053dc
FDA-2023-P-4596-0003,FDA,FDA-2023-P-4596,"Attachment 1 Mephyton Tablets DISC OB re: Citizen Petition from Lachman Consultant Services, Inc.",Supporting & Related Material,Background Material,2023-10-18T04:00:00Z,2023,10,,,2023-10-18T15:14:19Z,,0,0,09000064861058ee